Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_assertion type Assertion NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_head.
- NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_assertion description "[Compared with the putative low-activity genotypes, odds ratios (ORs) associated with predicted intermediate and high mEH activity genotypes were significantly increased for oropharyngeal cancers [OR = 1.8; 95% confidence interval (CI) = 1.0-3.3; and OR = 2.1; 95% CI = 1.0-4.5, respectively; P(trend) = 0.03] and laryngeal cancers (OR = 1.7; 95% CI = 1.0-3.1; and OR = 2.4; 95% CI = 1.1-5.1, respectively; P(trend) = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_provenance.
- NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_assertion evidence source_evidence_literature NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_provenance.
- NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_assertion SIO_000772 10676631 NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_provenance.
- NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_assertion wasDerivedFrom befree-20140225 NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_provenance.
- NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_assertion wasGeneratedBy ECO_0000203 NP475582.RAA7i3-ZpGZ42Bcd0AXWjdtvO-zHl4KFY1DI9pCZZqvHs130_provenance.